nach oben

Herzschrittmachertherapie + Elektrophysiologie

Erschienen in:

26.07.2021 | Herzrhythmusstörungen | EP Basics

Pulmonalvenenisolation mittels Radiofrequenzablation

verfasst von: Leon Iden, Sonia Busch, Univ.- Prof. Dr. med. Daniel Steven, Roland R. Tilz, Dong-In Shin, KR Julian Chun, Heidi Estner, Felix Bourier, David Duncker, Philipp Sommer, Andreas Metzner, Tilman Maurer, Nils-Christian Ewertsen, Henning Jansen, Andreas Rillig, Victoria Johnson, Till Althoff

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Katheterablation von Herzrhythmusstörungen hat sich für die meisten tachykarden Arrhythmieformen als primäre Behandlungsform etabliert. Hierbei ist die interventionelle Behandlung eines symptomatischen Vorhofflimmerns der medikamentösen Therapie überlegen, sodass die Durchführung einer Katheterablation zunehmend zum klinischen Alltag vieler Kliniken gehört. Die elektrische Isolation der Pulmonalvenen (PVI) stellt den Eckpfeiler der interventionellen Therapie sowohl von paroxysmalem als auch von persistierendem Vorhofflimmern dar. Dieser Artikel beschreibt die Durchführung einer Pulmonalvenenisolation mittels Radiofrequenzablation in Punkt-für-Punkt-Technik und soll eine praktische Anleitung für die Arbeit im Herzkatheterlabor sein. Diese Arbeit setzt eine Reihe von Artikeln fort, die für eine Weiterbildung im Bereich der speziellen Rhythmologie erstellt worden sind.

Nur mit Berechtigung zugänglich

Nathan H, Eliakim M (1966) The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation 34(3):412–422PubMed

Ho SY, Cabrera JA, Tran VH, Farre J, Anderson RH, Sanchez-Quintana D (2001) Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart 86(3):265–270PubMedPubMedCentral

Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339(10):659–666PubMed

Jais P, Hocini M, Macle L, Choi KJ, Deisenhofer I, Weerasooriya R et al (2002) Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 106(19):2479–2485PubMed

Fichtner S, Hessling G, Ammar S, Reents T, Estner HL, Jilek C et al (2013) A prospective randomized study comparing isolation of the arrhythmogenic vein versus all veins in paroxysmal atrial fibrillation. Clin Cardiol 36(7):422–426PubMedPubMedCentral

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association of cardio-thoracic surgery (EACTS). Eur Heart J 42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612CrossRefPubMed

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L et al (2018) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 20(1):e1–e160PubMed

Tilz RR, Chun KRJ, Deneke T, Kelm C, Piorkowski C, Sommer P, Stellbrink CS (2017) Positionspapier der Deutschen Gesellschaft für Kardiologie zur Kardioanalgosedierung. Kardiologe 11(11):369–382

Kuck K, Böcker D, Chun J, Deneke T, Hindricks G, Hoffmann E, Piorkowski C, Willems S (2017) Qualitätskriterien zur Durchführung der Katheterablation von Vorhofflimmern. Kardiologe 11(11):161–182

10.

Duncker D, Sommer P, Busch S, Tilz RR, Althoff T, Iden L et al (2021) Puncture techniques in invasive cardiac electrophysiology. Herzschrittmacherther Elektrophysiol 32(2):274–284PubMed

11.

Hutchinson MD, Garcia FC, Mandel JE, Elkassabany N, Zado ES, Riley MP et al (2013) Efforts to enhance catheter stability improve atrial fibrillation ablation outcome. Heart Rhythm 10(3):347–353PubMed

12.

Piorkowski C, Eitel C, Rolf S, Bode K, Sommer P, Gaspar T et al (2011) Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: a prospective, randomized study. Circ Arrhythm Electrophysiol 4(2):157–165PubMed

13.

14.

Schoene K, Arya A, Grashoff F, Knopp H, Weber A, Lerche M et al (2020) Oesophageal probe evaluation in radiofrequency ablation of atrial fibrillation (OPERA): results from a prospective randomized trial. Europace 22(10):1487–1494PubMed

15.

Grosse Meininghaus D, Blembel K, Waniek C, Kruells-Muench J, Ernst H, Kleemann T et al (2021) Temperature monitoring and temperature-driven irrigated radiofrequency energy titration do not prevent thermally induced esophageal lesions in pulmonary vein isolation: A randomized study controlled by esophagoscopy before and after catheter ablation. Heart Rhythm 18(6):926–934PubMed

16.

Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F et al (2014) Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 311(5):498–506PubMed

17.

Bisbal F, Benito E, Teis A, Alarcón F, Sarrias A, Caixal G et al (2020) Magnetic resonance imaging-guided fibrosis ablation for the treatment of atrial fibrillation: the ALICIA trial. Circ Arrhythm Electrophysiol 13(11):e8707PubMed

18.

Kottkamp H, Berg J, Bender R, Rieger A, Schreiber D (2016) Box isolation of fibrotic areas (BIFA): a patient-tailored substrate modification approach for ablation of atrial fibrillation. J Cardiovasc Electrophysiol 27(1):22–30PubMed

19.

Rolf S, Kircher S, Arya A, Eitel C, Sommer P, Richter S et al (2014) Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 7(5):825–833PubMed

20.

Zghaib T, Keramati A, Chrispin J, Huang D, Balouch MA, Ciuffo L et al (2018) Multimodal examination of atrial fibrillation substrate: correlation of left atrial bipolar voltage using multi-electrode fast automated mapping, point-by-point mapping, and magnetic resonance image intensity ratio. JACC Clin Electrophysiol 4(1):59–68PubMed

21.

Ammar-Busch S, Buiatti A, Tatzber A, Reents T, Bourier F, Semmler V et al (2020) Predictors of low voltage areas in persistent atrial fibrillation: is it really a matter of time? J Interv Card Electrophysiol 57(3):345–352PubMed

22.

Sim I, Bishop M, O’Neill M, Williams SE (2019) Left atrial voltage mapping: defining and targeting the atrial fibrillation substrate. J Interv Card Electrophysiol 56(3):213–227PubMedPubMedCentral

23.

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS). Eur Heart J 42(5):373–498PubMed

24.

Reddy VY, Grimaldi M, De Potter T, Vijgen JM, Bulava A, Duytschaever MF et al (2019) Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the QDOT-FAST trial. JACC Clin Electrophysiol 5(7):778–786PubMed

25.

Iwasawa J, Koruth JS, Petru J, Dujka L, Kralovec S, Mzourkova K et al (2017) Temperature-controlled radiofrequency ablation for pulmonary vein isolation in patients with atrial fibrillation. J Am Coll Cardiol 70(5):542–553PubMed

26.

Chee J, Kalogeropoulos AP, Almasry I, Singh A, Rashba E, Fan R (2021) Identification and endocardial ablation of the ligament of marshall for pulmonary vein isolation. JACC Clin Electrophysiol 7(3):283–291PubMed

27.

Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT et al (2005) Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation 111(2):127–135PubMed

28.

El Haddad M, Taghji P, Phlips T, Wolf M, Demolder A, Choudhury R et al (2017) Determinants of acute and late pulmonary vein reconnection in contact force-guided pulmonary vein isolation: identifying the weakest link in the ablation chain. Circ Arrhythm Electrophysiol 10(4):e4867PubMed

29.

Taghji P, El Haddad M, Phlips T, Wolf M, Knecht S, Vandekerckhove Y et al (2018) Evaluation of a strategy aiming to enclose the pulmonary veins with contiguous and optimized radiofrequency lesions in paroxysmal atrial fibrillation: a pilot study. JACC Clin Electrophysiol 4(1):99–108PubMed

30.

De Pooter J, Strisciuglio T, El Haddad M, Wolf M, Phlips T, Vandekerckhove Y et al (2019) Pulmonary vein reconnection no longer occurs in the majority of patients after a single pulmonary vein isolation procedure. JACC Clin Electrophysiol 5(3):295–305PubMed

31.

Phlips T, Taghji P, El Haddad M, Wolf M, Knecht S, Vandekerckhove Y et al (2018) Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol. Europace 20(Fi_3):f419–f427PubMed

32.

Wolf M, El Haddad M, De Wilde V, Phlips T, De Pooter J, Almorad A et al (2019) Endoscopic evaluation of the esophagus after catheter ablation of atrial fibrillation using contiguous and optimized radiofrequency applications. Heart Rhythm 16(7):1013–1020PubMed

33.

Duytschaever M, De Pooter J, Demolder A, El Haddad M, Phlips T, Strisciuglio T et al (2020) Long-term impact of catheter ablation on arrhythmia burden in low-risk patients with paroxysmal atrial fibrillation: the CLOSE to CURE study. Heart Rhythm 17(4):535–543PubMed

34.

Duytschaever M, Vijgen J, De Potter T, Scherr D, Van Herendael H, Knecht S et al (2020) Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial. Europace 22(11):1645–1652PubMed

35.

Leshem E, Zilberman I, Tschabrunn CM, Barkagan M, Contreras-Valdes FM, Govari A et al (2018) High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization. JACC Clin Electrophysiol 4(4):467–479PubMed

36.

Hoffmann P, Diaz Ramirez I, Baldenhofer G, Stangl K, Mont L, Althoff TF (2020) Randomized study defining the optimum target interlesion distance in ablation index-guided atrial fibrillation ablation. Europace 22(10):1480–1486PubMed

37.

Park CI, Lehrmann H, Keyl C, Weber R, Schiebeling J, Allgeier J et al (2014) Mechanisms of pulmonary vein reconnection after radiofrequency ablation of atrial fibrillation: the deterministic role of contact force and interlesion distance. J Cardiovasc Electrophysiol 25(7):701–708PubMed

38.

Jankelson L, Dai M, Aizer A, Bernstein S, Park DS, Holmes D et al (2021) Lesion sequence and catheter spatial stability affect lesion quality markers in atrial fibrillation ablation. JACC Clin Electrophysiol 7(3):367–377PubMed

39.

Barbhaiya CR, Kogan EV, Jankelson L, Knotts RJ, Spinelli M, Bernstein S et al (2020) Esophageal temperature dynamics during high-power short-duration posterior wall ablation. Heart Rhythm 17(5 Pt A):721–727PubMed

40.

Bourier F, Duchateau J, Vlachos K, Lam A, Martin CA, Takigawa M et al (2018) High-power short-duration versus standard radiofrequency ablation: insights on lesion metrics. J Cardiovasc Electrophysiol 29(11):1570–1575PubMed

41.

Kottmaier M, Popa M, Bourier F, Reents T, Cifuentes J, Semmler V et al (2020) Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Europace 22(3):388–393PubMed

42.

Winkle RA, Mohanty S, Patrawala RA, Mead RH, Kong MH, Engel G et al (2019) Low complication rates using high power (45–50 W) for short duration for atrial fibrillation ablations. Heart Rhythm 16(2):165–169PubMed

43.

Yavin HD, Leshem E, Shapira-Daniels A, Sroubek J, Barkagan M, Haffajee CI et al (2020) Impact of high-power short-duration radiofrequency ablation on long-term lesion durability for atrial fibrillation ablation. JACC Clin Electrophysiol 6(8):973–985PubMed

44.

Castrejón-Castrejón S, Martínez Cossiani M, Ortega Molina M, Escobar C, Froilán Torres C, Gonzalo Bada N et al (2020) Feasibility and safety of pulmonary vein isolation by high-power short-duration radiofrequency application: short-term results of the POWER-FAST PILOT study. J Interv Card Electrophysiol 57(1):57–65PubMed

45.

Chen S, Schmidt B, Bordignon S, Urbanek L, Tohoku S, Bologna F et al (2019) Ablation index-guided 50 W ablation for pulmonary vein isolation in patients with atrial fibrillation: procedural data, lesion analysis, and initial results from the FAFA AI high power study. J Cardiovasc Electrophysiol 30(12):2724–2731PubMed

46.

Wielandts JY, Kyriakopoulou M, Almorad A, Hilfiker G, Strisciuglio T, Phlips T et al (2021) Prospective randomized evaluation of high power during CLOSE-guided pulmonary vein isolation: the POWER-AF study. Circ Arrhythm Electrophysiol 14(1):e9112PubMed

47.

Piringer R, Deneke T, Foldyna B, Sonne K, Nentwich K, Ene E et al (2021) Incidence of ablation-induced esophageal injury associated with high-power short duration temperature-controlled pulmonary vein isolation using a specialized open-irrigated ablation catheter: a retrospective single-center study. J Cardiovasc Electrophysiol 32(3):695–703. https://doi.org/10.1111/jce.14883CrossRefPubMed

48.

Kaneshiro T, Amami K, Hijioka N, Nodera M, Yamada S, Yokokawa T et al (2021) Significance of contact force on esophageal thermal injury during relative high-power short-duration ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 14(6):e9897PubMed

49.

Osorio J, Hunter TD, Rajendra A, Zei P, Silverstein J, Morales G (2021) Predictors of clinical success after paroxysmal atrial fibrillation catheter ablation. J Cardiovasc Electrophysiol 32(7):1814–1821. https://doi.org/10.1111/jce.15028CrossRefPubMed

50.

Macle L, Khairy P, Weerasooriya R, Novak P, Verma A, Willems S et al (2015) Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial. Lancet 386(9994):672–679PubMed

51.

Kobori A, Shizuta S, Inoue K, Kaitani K, Morimoto T, Nakazawa Y et al (2015) Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking dormant electrical reconduction by adenosine triphosphate (UNDER-ATP) trial. Eur Heart J 36(46):3276–3287PubMed

52.

Steven D, Sultan A, Reddy V, Luker J, Altenburg M, Hoffmann B et al (2013) Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2‑center randomized trial. J Am Coll Cardiol 62(1):44–50PubMed

53.

Santangeli P, Marchlinski FE (2017) Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation. Heart Rhythm 14(7):1087–1096PubMed

54.

Zhao Y, Di Biase L, Trivedi C, Mohanty S, Bai R, Mohanty P et al (2016) Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction. Heart Rhythm 13(1):141–149PubMed

Titel: Pulmonalvenenisolation mittels Radiofrequenzablation
verfasst von: Leon Iden
Sonia Busch
Univ.- Prof. Dr. med. Daniel Steven
Roland R. Tilz
Dong-In Shin
KR Julian Chun
Heidi Estner
Felix Bourier
David Duncker
Philipp Sommer
Andreas Metzner
Tilman Maurer
Nils-Christian Ewertsen
Henning Jansen
Andreas Rillig
Victoria Johnson
Till Althoff
Publikationsdatum: 26.07.2021
Verlag: Springer Medizin
Schlagwörter: Herzrhythmusstörungen
Vorhofflimmern
Ablationstherapie
Herzrhythmusstörungen
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 3/2021
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI: https://doi.org/10.1007/s00399-021-00794-z

Das könnte Sie auch interessieren

EP Basics: Techniken der Elektrophysiologie

Passend zum Thema

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Vorhofflimmern

Die neue Leitlinie zur Behandlung von Herzklappenerkrankungen der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) ist ab jetzt als deutschsprachige Pocket-Leitlinien abrufbar. Die wichtigsten Neuerungen des Updates finden Sie hier von Prof. Dr. Helge Möllmann aus Dortmund für Sie zusammengefasst.

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Vorhofflimmern

Der interventionelle Verschluss des linken Vorhofohrs ist eine in den Leitlinien empfohlene Alternative zur oralen Antikoagulation bei Menschen mit Vorhofflimmern. Bei welchen Patientinnen und Patienten Sie konkret an diese Alternative denken sollten – dazu gibt Kardiologe PD Dr. Zisis Dimitriadis alltagstaugliche Tipps.

Abbott Structural Heart

Content Hub

Wir helfen Menschen mit Strukturellen Herzerkrankungen ihre Lebensqualität zu verbessern. Entdecken Sie unser einzigartiges Produktportfolio für ihre Patienten.

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

In-hospital complications in acute ST-elevation myocardial infarction depending on renal function

Mitteilungen aus der Arbeitsgruppe Elektrophysiologie und Rhythmologie (AGEP)

Feasibility of digital atrial fibrillation screening in an elderly population

Wide QRS complex tachycardia due to typical atrial flutter with accessory pathway conduction